[Cerebrovascular disorders and their treatment].
D000925:Anticoagulants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure; D001810:Blood Volume; D002245:Carbon Dioxide / Q000097:blood; D002533:Cerebral Angiography; D002560:Cerebrovascular Circulation; D002561:Cerebrovascular Disorders / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D003097:Collateral Circulation; D003937:Diagnosis, Differential; D004071:Digitalis Glycosides / Q000627:therapeutic use; D006801:Humans; D006863:Hydrogen-Ion Concentration; D009884:Ophthalmodynamometry; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D012039:Regional Blood Flow; D014655:Vascular Resistance; D014665:Vasodilator Agents / Q000627:therapeutic use
D000925:Anticoagulants; D000959:Antihypertensive Agents; D004071:Digitalis Glycosides; D014665:Vasodilator Agents; D002245:Carbon Dioxide; D010100:Oxygen
Zerebrale Durchblutungsstörungen und ihre Behandlung.